Berkeley, CA, United States of America

Venkataraman Sriram

USPTO Granted Patents = 7 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Venkataraman Sriram: Innovator in Immunotherapy

Introduction

Venkataraman Sriram, based in Berkeley, California, is a distinguished inventor known for his significant contributions to the field of immunotherapy. With a portfolio of five patents, Sriram is at the forefront of developing advanced therapeutic solutions aimed at enhancing immune responses and treating immune-related conditions.

Latest Patents

Among his latest innovations, Sriram has developed two noteworthy patents. The first is titled "Anti-TREM1 antibodies and related methods," which presents novel anti-TREM1 antibodies and describes methods for their application. This patent focuses on enhancing immune responses and provides techniques for treating conditions such as cancer by targeting and depleting non-stimulatory myeloid cells using these antibodies. The second patent, "Anti-MARCO antibodies and uses thereof," outlines the generation and utilization of anti-MARCO antibodies, further advancing therapeutic methodologies in immunology.

Career Highlights

Sriram plays a pivotal role at Pionyr Immunotherapeutics, Inc., where he focuses on innovative solutions that leverage the immune system's potential. His work is instrumental in bridging the gap between scientific research and clinical application.

Collaborations

Throughout his career, Sriram has collaborated with other prominent professionals in the field. Notable coworkers include Leonard G. Presta and Aritra Pal, who together contribute to the pioneering efforts in the development of novel immunotherapeutic approaches.

Conclusion

Venkataraman Sriram’s inventions not only demonstrate his commitment to scientific advancement but also hold promise for improved treatments in the realm of cancer and immune-related disorders. His ongoing contributions to immunotherapy reflect a dedication to enhancing human health through innovative methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…